"Expect a new licensee."
likely by sounds of CEO comment "and simplifies our commercial proposition for potential partners."
A deal based on pending results outcome (like Fuji), or just wait for the study report in 6-9 months?
Agree with the bargain and shares better than cash and we have another commercial shareholder in Tekcyte.
Tony Simula is a very experienced guy.
I expect they see upside from their allocation at that price.
"Expect a new licensee."likely by sounds of CEO comment "and...
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.005(1.82%) |
Mkt cap ! $48.78M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 28.5¢ | 26.5¢ | $71.17K | 257.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 145786 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 15000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |